candesartan has been researched along with hydrogen carbonate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ageloff, S; Beutler, KT; Brooks, HL; Fenton, RA; Knepper, MA; Masilamani, S; Nielsen, J; Packer, RK; Turban, S | 1 |
Boron, WF; Bouyer, P; Zhou, Y | 1 |
2 other study(ies) available for candesartan and hydrogen carbonate
Article | Year |
---|---|
Long-term regulation of ENaC expression in kidney by angiotensin II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzothiadiazines; Bicarbonates; Biphenyl Compounds; Diuretics; Epithelial Sodium Channels; Gene Expression Regulation; Immunoblotting; Infusion Pumps; Injections, Subcutaneous; Kidney; Kidney Cortex; Kidney Medulla; Kidney Tubules, Distal; Male; Mineralocorticoid Receptor Antagonists; Potassium; Protein Subunits; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Channels; Sodium Chloride Symporter Inhibitors; Sodium Chloride Symporters; Sodium Chloride, Dietary; Spironolactone; Symporters; Tetrazoles; Time Factors | 2003 |
Role of the AT1A receptor in the CO2-induced stimulation of HCO3- reabsorption by renal proximal tubules.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Bicarbonates; Biphenyl Compounds; Carbon Dioxide; Data Interpretation, Statistical; Female; Hydrogen-Ion Concentration; In Vitro Techniques; Kidney Tubules, Proximal; Mice; Mice, Knockout; Perfusion; Rabbits; Receptor, Angiotensin, Type 1; Saralasin; Signal Transduction; Tetrazoles | 2007 |